MedPath

Pain Relief by Intra-Peritoneal Ropivacaine During Gynecological Laparoscopy

Phase 3
Completed
Conditions
Laparoscopic Surgical Procedures
Interventions
Device: Aeroneb Pro Nezulizer, Aerogen, Ireland
Drug: ropivacaine
Registration Number
NCT00433316
Lead Sponsor
Carmel Medical Center
Brief Summary

In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecological laparoscopic surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • Elective gynecologic laparoscopic surgery including unilateral or bilateral salpingo-oopherectomy or ovarian cystectomy.
  • The patient is not participating in other medical study at present or in the last 30 days.
  • The patient signed on an informed consent.
  • Age 18 years and above.
  • ASA (American Society of Anesthesiologists) physical status grade 1- 2.
Read More
Exclusion Criteria
  • Allergy to Ropivacaine, other local anesthetics or other medications listed in the protocol.
  • The patient is participating in other medical experiment at present or in the last 30 days.
  • Acute Pelvic Inflammatory Disease.
  • Coumadin or Aspirin treatment.
  • ASA physical status grade 3-4.
  • Age < 18 years.
  • Significant arrythmias
  • Analgesic treatment for chronic pain
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlAeroneb Pro Nezulizer, Aerogen, IrelandReceiving 10ml of saline
studyropivacaineReceiving 10ml of 1% ropivacaine
Primary Outcome Measures
NameTimeMethod
VAS scoreearly post-operative
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

the Carmel Medical Center Ambulatory Gynecoendoscopic Unit

🇮🇱

Haifa, Israel

© Copyright 2025. All Rights Reserved by MedPath